We again observed fewer DNase I hypersensitive sites overlapping enhancers (Fig. 2C,D) and a greater number of DNase I sites overlapping CTCF sites in cancer cells (Fig. 2C,D), supporting the NOMe-seq results (Fig. 2A,B). Here, CTCF is linked to cancer.